Your browser is no longer supported. Please, upgrade your browser.
IRIDEX Corporation
Index- P/E- EPS (ttm)-0.19 Insider Own2.10% Shs Outstand15.65M Perf Week-6.56%
Market Cap113.45M Forward P/E- EPS next Y-0.23 Insider Trans0.00% Shs Float11.46M Perf Month4.81%
Income-2.50M PEG- EPS next Q-0.14 Inst Own27.20% Short Float1.20% Perf Quarter13.30%
Sales46.50M P/S2.44 EPS this Y28.90% Inst Trans-4.32% Short Ratio2.80 Perf Half Y-0.13%
Book/sh1.72 P/B4.31 EPS next Y14.80% ROA-6.40% Target Price10.50 Perf Year270.50%
Cash/sh1.72 P/C4.31 EPS next 5Y30.00% ROE-11.50% 52W Range1.60 - 9.71 Perf YTD195.22%
Dividend- P/FCF10.60 EPS past 5Y-63.70% ROI-33.40% 52W High-23.73% Beta1.21
Dividend %- Quick Ratio3.30 Sales past 5Y-2.70% Gross Margin43.60% 52W Low363.12% ATR0.35
Employees89 Current Ratio4.00 Sales Q/Q116.10% Oper. Margin-11.00% RSI (14)48.54 Volatility4.99% 4.85%
OptionableYes Debt/Eq0.00 EPS Q/Q142.40% Profit Margin-5.40% Rel Volume1.02 Prev Close7.60
ShortableYes LT Debt/Eq0.00 EarningsAug 12 AMC Payout- Avg Volume49.03K Price7.41
Recom- SMA20-0.74% SMA500.96% SMA2008.91% Volume49,872 Change-2.50%
Nov-03-17Resumed ROTH Capital Buy
Dec-21-16Initiated ROTH Capital Buy
Jan-26-16Initiated Singular Research Buy $11.50
Jan-03-07Initiated First Albany Buy $15.50
Sep-30-21 04:05PM  
Sep-21-21 09:47AM  
Sep-08-21 08:47AM  
Aug-12-21 06:35PM  
Aug-09-21 04:05PM  
Jul-29-21 04:05PM  
Jun-23-21 03:55AM  
Jun-13-21 10:58PM  
May-11-21 04:05PM  
May-04-21 03:00PM  
Apr-27-21 04:05PM  
Mar-23-21 12:52PM  
Mar-22-21 05:43PM  
Mar-19-21 10:46AM  
Mar-15-21 12:30PM  
Mar-10-21 04:05PM  
Mar-08-21 04:05PM  
Mar-04-21 12:30PM  
Mar-02-21 04:05PM  
Jan-14-21 01:36AM  
Jan-11-21 04:05PM  
Dec-22-20 04:05PM  
Nov-11-20 06:41AM  
Nov-09-20 06:35PM  
Nov-06-20 10:19AM  
Nov-03-20 04:05PM  
Nov-02-20 12:31PM  
Oct-26-20 04:05PM  
Aug-19-20 02:53PM  
Aug-06-20 04:05PM  
Jul-30-20 12:33PM  
Jul-23-20 04:05PM  
Jun-16-20 03:44AM  
May-16-20 10:05AM  
May-11-20 08:15PM  
Apr-28-20 05:31PM  
Apr-21-20 08:00AM  
Mar-30-20 04:05PM  
Mar-28-20 12:11AM  
Mar-15-20 09:02AM  
Mar-12-20 06:45PM  
Feb-28-20 04:03PM  
Feb-26-20 04:03PM  
Jan-24-20 08:05AM  
Jan-13-20 04:05PM  
Dec-10-19 09:08AM  
Nov-29-19 01:35PM  
Nov-07-19 04:05PM  
Nov-05-19 04:05PM  
Oct-31-19 10:35AM  
Oct-28-19 04:05PM  
Oct-24-19 04:03PM  
Oct-21-19 10:52AM  
Sep-25-19 10:39AM  
Sep-24-19 02:24PM  
Sep-11-19 05:11PM  
Sep-05-19 06:44PM  
Sep-04-19 12:38PM  
Aug-28-19 09:23AM  
Aug-06-19 06:55PM  
Jul-30-19 10:38AM  
Jul-23-19 04:05PM  
Jul-19-19 11:50AM  
Jul-03-19 09:27PM  
Jun-13-19 10:25AM  
May-21-19 04:03PM  
May-10-19 02:31PM  
May-02-19 08:25PM  
Apr-29-19 02:41PM  
Apr-25-19 10:34AM  
Apr-18-19 04:05PM  
Apr-03-19 03:14PM  
Apr-02-19 06:45PM  
Apr-01-19 12:48PM  
Mar-29-19 06:48PM  
Mar-18-19 04:05PM  
Mar-07-19 02:35AM  
Mar-06-19 08:00AM  
Mar-05-19 04:08PM  
Mar-04-19 08:37AM  
Feb-26-19 08:00AM  
Feb-21-19 10:19AM  
Feb-12-19 08:00AM  
Jan-15-19 10:26AM  
Jan-08-19 04:05PM  
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.